To Evaluate the Safety and Tolerability of SYHX2001 in Patients With Advanced or Metastatic Solid Tumors
Status:
Not yet recruiting
Trial end date:
2026-01-06
Target enrollment:
Participant gender:
Summary
This is a Phase 1, open-label, multicenter, dose escalation and expansion study to evaluate
the safety, tolerability, pharmacokinetics, and pharmacodynamics of the experimental
drug(SYHX2001) in previously treated patients with advanced or metastatic cancer.